Stein, A. et al. 2014. Docetaxel, oxaliplatin and capecitabine (TEX regimen) in patients with metastatic gastric or gastro-esophageal cancer: Results of a multicenter phase I/II study. Acta Oncologica. 53, 3 (Mar. 2014), 392–398. DOI:https://doi.org/10.3109/0284186X.2013.833346.